Utilizing proprietary technologies and expertise, we develop peptide drugs, lyophilized powders, dry peptides, and peptide capsules that are both effective and commercially viable for research purposes. These products employ bioconjugation strategies that enable drugs to be combined at the C-terminus, N-terminus, or within the peptide sequence. This service is ideal for creating peptide-based conjugates, providing a fast and efficient solution for developing novel therapeutic agents.

Each capsules contain 1.5mg of filled peptides for research purposes.Please do not add this item to the shopping cart, as it is contract-manufactured upon order. Contact us for minimum quantity, bulk pricing, or packaging inquiries. MQTY runs from 140,000 to 1.64MM counts.